Search for a cure: The story of Flurizan (approx. 31 min.)
Scientists discuss the discovery of Flurizan (tarenflurbil) as a potential Alzheimer's drug, its phase III trial, and the negative results unveiled to the public at ICAD 2008. Researchers give possible explanations for Flurizan's failure and explain how data gathered during the trial will help advance the field.
This video is part of the "THE ALZHEIMER'S PROJECT," a presentation of HBO Documentary Films and the National Institute on Aging at the National Institutes of Health in association with the Alzheimer's Association, The Fidelity® Charitable Gift Fund and Geoffrey Beene Gives Back® Alzheimer's Initiative.
|
